Related Experiment Video
Updated: Jun 7, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Association between lipoprotein(a) and coronary artery disease]
1Department of Cardiology, Beijing Anzhen Hospital, Capital University of Medical Science, Beijing 100029, China.
Insights
Elevated lipoprotein(a) [Lp(a)] levels are strongly associated with coronary artery disease (CAD). This study identifies Lp(a) as the most potent independent risk factor for diagnosing CAD.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Background:
- Coronary artery disease (CAD) poses a significant global health burden.
- Identifying reliable biomarkers for CAD risk is crucial for early diagnosis and prevention.
- Lipoprotein(a) [Lp(a)] has been implicated as a potential risk factor, but its independent predictive value requires further investigation.
Purpose of the Study:
- To investigate the correlation between plasma lipoprotein(a) [Lp(a)] levels and the presence of coronary artery disease (CAD).
- To determine if Lp(a) serves as an independent risk factor for CAD, beyond traditional lipid profiles.
Main Methods:
- A cohort of 1011 patients undergoing coronary angiography for chest pain was analyzed.
- Patients were categorized into CAD (n=613) and non-CAD control (n=398) groups.
- Plasma levels of Lp(a), apolipoproteinA1 (apoA1), apolipoproteinB (apoB), triglyceride (TG), total cholesterol (TC), HDL-C, and LDL-C were measured. The LDL-C/HDL-C ratio was calculated, and multivariate logistic regression was employed.
Main Results:
- Patients with CAD exhibited significantly higher plasma levels of Lp(a), TG, TC, LDL-C, apoB, and a higher LDL-C/HDL-C ratio compared to the control group (P < 0.05).
- Multivariate logistic regression analysis identified Lp(a) as the most powerful independent risk factor for diagnosing CAD, with an odds ratio (OR) of 16.201 (95% CI: 3.477 - 75.489, P = 0.0001).
Conclusions:
- Plasma lipoprotein(a) [Lp(a)] is a significant independent risk factor for coronary artery disease (CAD).
- Elevated Lp(a) levels are strongly predictive of CAD diagnosis, highlighting its importance in clinical risk assessment.
Objective:
To explore the correlation between plasma level of lipoprotein(a) [Lp(a)] and coronary artery disease (CAD).
Method:
A total of 1011 patients underwent coronary angiography in our department from October 2007 to March 2009 due to chest pain were included, 613 cases (60.6%) were diagnosed as CAD and the remaining 398 non-CAD patients (39.4%) served as control. Lp(a), apolipoproteinA1 (apoA1), apolipoproteinB (apoB) were detected by immunoturbidimetry method, triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were measured by enzymatic approach. LDL-C/HDL-C ratio was calculated, multivariate logistic regression analysis was performed.
Results:
(1) The values of Lp(a), TG, TC, LDL-C and apoB, and the ratio of LDL-C/HDL-C in CAD group were significantly higher in CAD group [(170.00 ± 160.00) mg/L, (1.84 ± 0.90) mmol/L, (4.86 ± 0.88) mmol/L, (3.31 ± 0.72) mmol/L, (0.97 ± 0.17) mmol/L and 3.39 ± 0.93] compared to those in control group [(120.00 ± 100.00) mg/L, (1.67 ± 0.72) mmol/L, (4.61 ± 0.95) mmol/L, (2.96 ± 0.80) mmol/L, (0.90 ± 0.18) mmol/L and 2.89 ± 0.92, all P < 0.05]. (2) Multivariate logistic regression analysis (forward method) indicated that Lp(a) (OR = 16.201, 95%CI 3.477 - 75.489, P = 0.0001) was the most powerful independent risk factor for diagnosing coronary artery disease.
Conclusions:
Lp(a) is the most powerful independent risk factors for diagnosing coronary artery disease.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations